INFLUENZA A (H5N1) MONOVALENT VACCINE, ADJUVANTED AUDENZ
LIVE

Serial Number

98003147

Owner

Seqirus UK Limited

Attorney

Nancy Sabarra

Filing Date

May 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INFLUENZA A (H5N1) MONOVALENT VACCINE, ADJUVANTED AUDENZ Trademark

Serial Number: 98003147 • Registration: 7629690

INFLUENZA A (H5N1) MONOVALENT VACCINE, ADJUVANTED AUDENZ is a trademark filed by Seqirus UK Limited on May 18, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Seqirus UK Limited (138 trademarks)

Point, 29 Market Street

Entity Type: 98

Trademark Details

Filing Date

May 18, 2023

Registration Date

December 31, 2024

Published for Opposition

November 12, 2024

Goods & Services

Vaccines; vaccines for human use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 31, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 3, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 12, 2024 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 3, 2023 AMPX
ASSIGNED TO LIE
Nov 3, 2023 ALIE
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 23, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2023 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 1, 2023 PARI
NEW APPLICATION ENTERED
May 22, 2023 NWAP